Wu Wei Zi (Schisandra chinensis).

Silymarin stabilises hepatocyte membranes and acts as a direct antioxidant, while schisandra lignans induce phase II conjugating enzymes and glutathione S-transferase. The two support liver handling by different mechanisms.

Schisandra lignans raise glutathione S-transferase activity, and that enzyme needs glutathione as its co-substrate. NAC supplies the cysteine that limits glutathione synthesis, so it feeds the step schisandra accelerates.

Conjugation reactions upregulated by schisandra lignans consume glutathione directly. Supplying it alongside keeps the pool from being the limiting factor.

Lipoic acid and its reduced form regenerate glutathione and vitamin C from their oxidised states. That keeps the antioxidant pool schisandra draws on turning over.

Glutathione peroxidase is a selenoenzyme, and it works on the same peroxide load that schisandra's induced enzymes handle. Without adequate selenium that arm of the system cannot be built.

Schisandra lignans inhibit CYP3A4 and P-glycoprotein, while St John's wort is a strong inducer of both. Taken together they push the handling of co-administered compounds in opposite directions and make exposure unpredictable.

Berberine and schisandra lignans both inhibit CYP3A4 and P-glycoprotein activity. Stacking them raises the exposure of anything else in the formula that depends on those enzymes for clearance.

Schisandra lignans such as schisandrin A and gomisin A are well-characterised modulators of CYP3A and of the P-glycoprotein efflux pump, and curcumin acts on the same two systems. Taken together they can change how much of a co-administered compound reaches the bloodstream, in either direction depending on timing. This is established pharmacology and it applies to anything else in the formula that is a CYP3A or P-glycoprotein substrate.

Piperine inhibits CYP3A4 and P-glycoprotein, the same pair that schisandra lignans act on, so combining them can raise systemic exposure to other actives in the same capsule more than either would alone. Formulators using both should account for that when setting doses of anything else in the blend. The interaction is textbook rather than trial-derived for this specific pair.

Quercetin inhibits several CYP isoforms and P-glycoprotein in vitro, overlapping with the lignan effects of schisandra fruit. The practical consequence is on the disposition of co-administered compounds rather than on either polyphenol itself. Read it as a formulation caution alongside the antioxidant rationale.

Both botanicals have been reported to alter hepatic drug-metabolising enzyme activity, and stacking two enzyme modulators makes the net effect on a third compound harder to predict. The relevant caution is exposure to anything else being taken. No trial has measured the pair.

Schisandra and rhodiola are the two herbs most often combined in the adaptogen literature, where both are described as modulating the stress-response axis. Reviews of adaptogens name them together in that framing. The pairing rests on review-level and traditional grounding rather than a controlled combination trial.

Eleuthero, rhodiola and schisandra form the classic three-herb adaptogen combination in the Eastern European research tradition and appear together in review coverage of that class. The rationale is shared stress-axis framing rather than a measured additive effect. Confidence sits at the level of a narrative review.

Multi-herb stress formulas commonly place schisandra alongside ashwagandha, and at least one randomised placebo-controlled design has evaluated such a combination as a whole. A multi-herb trial cannot attribute any result to one of its components. The pairing is formulation convention with trial-level exposure of the blend, not of the herb alone.

Both are staples of tonifying Chinese formulas and are routinely combined in commercial adaptogen blends. The basis is traditional use and market convention. No combination trial exists.

Dang gui and wu wei zi appear together in classical blood- and fluid-supporting prescriptions. This is a historical pairing recorded in the formulary literature. Nothing measures it in a modern controlled design.

Liquorice root is the harmonising herb in a large share of classical Chinese formulas containing schisandra, added to bind the prescription together rather than for an effect of its own. The role is formulation convention. Liquorice carries its own mineralocorticoid caution at sustained intake.

Catechins and schisandra lignans are both handled by hepatic phase I and phase II enzymes and both have been reported to modulate transporter activity. Stacking two hepatically-handled botanical concentrates increases the load on the same clearance routes. Read this as a caution rather than a benefit pairing.

Schisandra fruit carries lignans and, in the seed, tocopherols, and its antioxidant peptides and phenolics act largely as radical scavengers in chemical assays. Vitamin E works in the lipid phase where those water-soluble constituents do not reach. The two therefore cover different compartments of the same chemistry, measured in assays rather than in people.

Ascorbate regenerates oxidised tocopherol at the membrane surface, which is the standard recycling relationship in any formula combining a lipid antioxidant with a polyphenol-rich botanical. Schisandra phenolics contribute scavenging capacity in the aqueous phase. This is laboratory antioxidant chemistry, not a clinical outcome.

Both appear in evening and stress-support blends in the Chinese materia medica tradition. The pairing is a formulation convention with a long history of co-use. No controlled combination data exist.

Schisandra polysaccharides are fermentable plant carbohydrates, and preclinical work has linked schisandra preparations to shifts in gut bacterial populations including Akkermansia and to downstream tryptophan and bile acid metabolites. Those are animal-model observations of composition, not demonstrated effects in people. Any combination with a probiotic strain is untested.

The polysaccharide fraction of schisandra fruit behaves as a fermentable substrate in animal models, the same general category as inulin. Combining two fermentable substrates increases total gas-forming load for sensitive users. This is a mechanistic classification rather than a measured additive benefit.

Taurine conjugates bile acids, and preclinical schisandra work has centred on bile acid pool composition as a mechanism. The two therefore touch the same metabolite class from different directions. Human relevance of the pairing has not been examined.